[ad_1] Xencor stock rallies 24% amid drug development updates [ad_2] Source: Seekingalpha
Browsing: Development
[ad_1] Xencor stock rallies 24% amid drug development updates [ad_2] Source: Seekingalpha
[ad_1] Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long…
[ad_1] Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long…